Menu
Search for
Home
News
Entertainment
Business
Sports
Games
Technology
Health
GSK
Health
Admin
October 30, 2024
0
7
The study demonstrates the effectiveness of the adjuvanted RSV vaccine in people over 60 years of age.
Health
Admin
October 30, 2024
0
11
GSK is starting a study to test the cost-effectiveness of its RSV vaccine in Spanish adults.
Health
Admin
February 26, 2024
0
139
86% of the population underestimate the risk of contracting shingles
Back to top button
Close
Search for